Hipgnosis Songs Fund Agrees to $1.4 Billion Concord Takeover — Update
By Ian Walker
Hipgnosis Songs Fund, home to the catalogue of artists such as Neil Young, Shakira and Red Hot Chili Peppers, agreed to a $1.40 billion takeover by Apollo-backed music company Concord Chorus.
Under the deal, accepting shareholders of the London-listed song catalog fund will get $1.16 in cash for each share held, or about 93.2 pence, the companies said Thursday.
The offer price is a 32% premium to the company's closing price of 70.50 pence on Wednesday. Shares at 0815 GMT were up 22.10 pence, or 31%, at 92.60 pence. They are currently up 8.2% over the past 12 months.
Concord, headquartered in Nashville, Tenn., is an active buyer of music rights, including the catalogues of Phil Collins and his Genesis bandmates Tony Banks and Mike Rutherford. It is owned by Alchemy Copyrights.
Apollo Capital Management has agreed to provide financing for the acquisition in the form of debt capital, as well as a minority, indirect equity interest in the Concord-controlled Bidco.
Hipgnosis appointed advisors on Nov. 23 to conduct due diligence on its assets, and asked its investment advisor to propose alternative terms for its future arrangements.
The decision followed shareholders' rejection of a plan to sell 29 music catalogs to Hipgnosis Songs Capital and continuation of Hipgnosis as a closed-end investment company.
It most recently said that the company won't restart paying dividends after an independent report estimated that the value of the company's assets was lower than previous calculations.
The company's portfolio was most recently valued at $1.95 billion, down from $2.62 billion at Sept. 30.
The deal agreed Thursday includes an extra $25 million if Concord and the company's investment advisor--Blackstone-backed Hipgnosis Song Management--reach agreement on the termination of the investment advisory agreement by a set deadline.
The Concord deal has the support of Hipgnosis shareholders owning 29.38 of its issued share capital.
"The acquisition represents an attractive opportunity for our shareholders to immediately realize their holding at a premium, mitigating the risks we see ahead to achieving a material improvement in the share price," Hipgnosis Chairman Robert Naylor said.
He added that the board believes Concord is the right owner to take on the Hipgnosis catalogue and manage it in the interests of composers and performers.
Write to Ian Walker at ian.walker@wsj.com
(END) Dow Jones Newswires
April 18, 2024 05:04 ET (09:04 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
What’s Happening in the Markets This Week
-
4 Top Dividend-Paying REIT Stock Picks
-
After Earnings, Is Netflix Stock a Buy, a Sell, or Fairly Valued?
-
P-CAPE: A Better Way for Investors to Estimate Future Returns
-
Which Stocks Have Driven the Stealth Large-Value Rally?
-
Forecasts for Q2 GDP Report Show a Healthy but Slowing Economy
-
5 Stocks to Buy as the Market Rally Broadens
-
4 Top US Travel Stock Picks
-
How Do Interest Rates Affect Stock Market Returns?
-
American Airlines Earnings: Ticket Distribution Misstep Affected Results
-
Going Into Earnings, Is Albemarle Stock a Buy, a Sell, or Fairly Valued?
-
3 Top Cybersecurity Stock Picks for Long-Term Investors
-
AbbVie Earnings: Firm Sees Strong Next-Generation Immunology Drugs Sales
-
Ford Earnings: Warranty Problems on Older Vehicles Slam Results
-
ServiceNow Earnings: Operating on a Higher Plane Within Enterprise Software